Skip to content

SG&A at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$159.42M-10.3%
STERIS logo
STERISSTE
$351.8M+5.4%
Fortive logo
FortiveFTV
$417.3M+2.2%
Natera, Inc. logo
Natera, Inc.NTRA
$327.94M+22.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$551M+0.9%
Waste Management logo
Waste ManagementWM
$707M+2.9%

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's SG&A?
Sotera Health (SHC) reported SG&A of $68.21M in Q1 2026.
How has Sotera Health's SG&A changed year-over-year?
Sotera Health's SG&A increased by 8.2% year-over-year, from $63.06M to $68.21M.
What is the long-term trend for Sotera Health's SG&A?
Over 4 years (2021 to 2025), Sotera Health's SG&A has grown at a 6.3% compound annual growth rate (CAGR), from $198.16M to $252.76M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.